SEC Form 4 · accession 0001209191-15-037973
INFINITY PHARMACEUTICALS, INC. · INFI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vito J. Palombella
Officer — Chief Scientific Officer
Period of report
Apr 30, 2015
Accepted (ET)
May 1, 2015 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 30, 2015 | M | 4,737 | $2.04 | A | 5,605 | D | |
| Common Stock | holding | — | — | — | 6,741 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.04 | Apr 30, 2015 | M | 4,737 | D | May 10, 2005 | May 10, 2015 | Common Stock | 4,737 | 0 | D |
Explanation of responses
- F1This stock option was granted under the issuer's Pre-Merger Stock Incentive Plan, which permits the early exercise of unvested stock options in exchange for shares of restricted stock that are subject to a right of repurchase by the issuer that lapses in accordance with the vesting schedule of the original option. This option is fully vested.